Literature DB >> 15466267

Chronic uremia attenuates growth hormone-induced signal transduction in skeletal muscle.

Di Fei Sun1, Zhilan Zheng, Padmaja Tummala, Jun Oh, Franz Schaefer, Ralph Rabkin.   

Abstract

Malnutrition and muscle wasting are common in chronic renal failure (CRF) and adversely affect morbidity and mortality. Contributing to the muscle wasting is resistance to growth hormone (GH). For testing whether impaired GH signaling is a cause of the skeletal muscle GH resistance and for elucidating its mechanisms, muscle GH signaling and action were studied in GH-deficient rats with surgically induced CRF and sham-operated pairfed control rats. GH treatment increased gastrocnemius muscle IGF-1 mRNA levels significantly in control but not in CRF rats. GH-activated Janus-associated kinase 2 (JAK2)-signal transducers and activators of transcription 5 (STAT5) signaling was impaired in CRF rats, despite normal GH receptor (GHR), JAK2, and STAT5 protein levels. Phosphorylation of the GHR, JAK2, and STAT5 in response to GH was depressed by nearly half in CRF (P < 0.05), and nuclear phospho-STAT5 levels were depressed by approximately one third (P < 0.01). GH-stimulated suppressors of cytokine signaling 2 mRNA levels were significantly higher in CRF. This may be related to inflammatory cytokine activity because C-reactive protein levels were elevated. Muscle protein-tyrosine phosphatase activity was also increased significantly by twofold. In conclusion, rats with CRF acquire skeletal muscle resistance to GH that is caused at least in part by impaired JAK2-GHR-STAT5 phosphorylation and nuclear STAT5 translocation. Furthermore, it seems that the attenuated JAK2-STAT5 phosphorylation may be caused by at least two different processes. One involves depressed phosphorylation of the signaling proteins because of increased suppressors of cytokine signaling 2 expression that may be linked to low-grade inflammation. The other may involve increased signaling protein dephosphorylation because of heightened protein-tyrosine phosphatase activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15466267     DOI: 10.1097/01.ASN.0000139492.36400.6C

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  22 in total

Review 1.  Suppressors of cytokine signaling in health and disease.

Authors:  Jane C Tan; Ralph Rabkin
Journal:  Pediatr Nephrol       Date:  2005-02-19       Impact factor: 3.714

Review 2.  Mechanisms of muscle wasting in chronic kidney disease.

Authors:  Xiaonan H Wang; William E Mitch
Journal:  Nat Rev Nephrol       Date:  2014-07-01       Impact factor: 28.314

Review 3.  Nutrition and growth in children with chronic kidney disease.

Authors:  Lesley Rees; Robert H Mak
Journal:  Nat Rev Nephrol       Date:  2011-09-27       Impact factor: 28.314

Review 4.  Longitudinal growth in children following kidney transplantation: from conservative to pharmacological strategies.

Authors:  Tim Ulinski; Pierre Cochat
Journal:  Pediatr Nephrol       Date:  2006-05-10       Impact factor: 3.714

5.  Growth plate alterations in chronic kidney disease.

Authors:  Ángela Fernández-Iglesias; José Manuel López; Fernando Santos
Journal:  Pediatr Nephrol       Date:  2018-12-14       Impact factor: 3.714

6.  Acromegaly and end-stage renal disease: a diagnostic challenge.

Authors:  K Müssig; B Gallwitz; M B Ranke; M Horger; H U Häring; H J Quabbe
Journal:  J Endocrinol Invest       Date:  2006-09       Impact factor: 4.256

Review 7.  The growth hormone-insulin-like growth factor-I axis in chronic kidney disease.

Authors:  Robert H Mak; Wai W Cheung; Charles T Roberts
Journal:  Growth Horm IGF Res       Date:  2007-09-07       Impact factor: 2.372

8.  Endotoxin-induced growth hormone resistance in skeletal muscle.

Authors:  Yu Chen; Sumita Sood; Vidya M R Krishnamurthy; Peter Rotwein; Ralph Rabkin
Journal:  Endocrinology       Date:  2009-05-14       Impact factor: 4.736

9.  Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophy.

Authors:  Liping Zhang; Xiaonan H Wang; Huiling Wang; Jie Du; William E Mitch
Journal:  J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 10.121

Review 10.  Frailty phenotype and chronic kidney disease: a review of the literature.

Authors:  Carlos G Musso; Jose R Jauregui; Juan F Macías Núñez
Journal:  Int Urol Nephrol       Date:  2015-09-28       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.